GMEDGlobus Medical, Inc.
What is the market doing?
No clear lean: nothing decisive, though in a downtrend (−12% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −12% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 2.2% since the previous count, up from 4.0% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How GMED is trading
Globus Medical, Inc. is +34% over the past year while the S&P 500 is +18%: 15 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −12%
vs 200-day average · a clear downtrend
- RSI (14)
- 52
RSI (14) · neutral
- Below its 52-week high
- 23%
Below its 52-week high
Details›
- Last close2026-10-09
- $74.65
- 1 monthS&P 500 +2.7%
- +1.4%
- 1 yearS&P 500 +18%
- +34%
- 5 yearsS&P 500 +88%
- −7.0%
- vs 50-day average$79.06
- −5.6%
- 52-week high
- $96.82
- 52-week low
- $55.10
- Annualised volatility
- 44%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$6.4M
| Year | Return |
|---|---|
| 2026 (year to date) | −15% |
| 2025 | +5.6% |
| 2024 | +55% |
| 2023 | −28% |
| 2022 | +2.9% |
| 2021 | +11% |
| 2020 | +11% |
| 2019 | +36% |
| 2018 | +5.3% |
| 2017 | +66% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 6 of 10 | +1.5% |
| Feb | 10 | 7 of 10 | −1.8% |
| Mar | 10 | 4 of 10 | −1.2% |
| Apr | 10 | 6 of 10 | +1.2% |
| May | 10 | 6 of 10 | +1.4% |
| Jun | 10 | 6 of 10 | +0.06% |
| Jul | 11 | 7 of 11 | +0.22% |
| Aug | 11 | 8 of 11 | +3.6% |
| Sep | 11 | 3 of 11 | −3.6% |
| Oct | 11 | 7 of 11 | +1.7% |
| Nov | 10 | 6 of 10 | +8.7% |
| Dec | 10 | 7 of 10 | +5.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.